Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis

Published:2023-06-17 Issue:6 Volume:11 Page:1739
ISSN:2227-9059
Container-title:Biomedicines
language:en
Short-container-title:Biomedicines

Author:

Cîrjaliu Roxana-Elena¹²^ORCID,Deacu Mariana²³,Gherghișan Ioana¹⁴,Marghescu Angela-Ștefania⁵⁶^ORCID,Enciu Manuela²³,Băltățescu Gabriela Izabela⁷^ORCID,Nicolau Antonela Anca⁷^ORCID,Tofolean Doina-Ecaterina¹²^ORCID,Arghir Oana Cristina¹⁴^ORCID,Fildan Ariadna-Petronela¹⁴

Affiliation:

1. Department of Pneumology, Faculty of Medicine, “Ovidius” University of Constanta, 900470 Constanta, Romania

2. Clinical Emergency “St. Andrew” Hospital of Constanta, 900591 Constanta, Romania

3. Department of Anatomopathology, Faculty of Medicine, “Ovidius” University of Constanta, 900470 Constanta, Romania

4. Pneumology Hospital of Constanta, 900002 Constanta, Romania

5. Department of Anatomopathology, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania

6. Pneumology Institute “Marius Nasta”, 50158 Bucharest, Romania

7. Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology-CEDMOG, “Ovidius” University of Constanta, 900591 Constanta, Romania

Abstract

This review brings together the current knowledge regarding the risk factors and the clinical, radiologic, and histological features of both post-COVID-19 pulmonary fibrosis (PCPF) and idiopathic pulmonary fibrosis (IPF), describing the similarities and the disparities between these two diseases, using numerous databases to identify relevant articles published in English through October 2022. This review would help clinicians, pathologists, and researchers make an accurate diagnosis, which can help identify the group of patients selected for anti-fibrotic therapies and future therapeutic perspectives.

Publisher

MDPI AG

Subject

General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)

Link

https://www.mdpi.com/2227-9059/11/6/1739/pdf

Reference118 articles.

1. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19);Bourgonje;J. Pathol.,2020

2. Pathological findings of COVID-19 associated with acute respiratory distress syndrome;Xu;Lancet Respir. Med.,2020

3. Infection fatality rate of COVID-19 inferred from seroprevalence data;Ioannidis;Bull. World Health Organ.,2021

4. Post COVID-19 pulmonary fibrosis. Is it real threat?;Rai;Indian J. Tuberc.,2021

5. Novel Coronavirus Disease 2019 (COVID-19) Pneumonia Progression Course in 17 Discharged Patients: Comparison of Clinical and Thin-Section Computed Tomography Features During Recovery;Han;Clin. Infect. Dis.,2020